View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AJ24 Publication ID: 2026 
Title: ●Amendment and Revocation of Organizational Information Regulations 
Abstract:

The rule amends FDA's organizational information regulations in 21 CFR part 5 (subpart M, 5.1100 to 5.1110) to direct the public to up-to-date information on the Agency's organization (including its central and field offices) available on the Agency's website, as well as to information on relevant website and email addresses for FDA offices.  The final rule also revokes certain regulations that are no longer necessary with this amendment.  These changes provide the public with a uniform source of Agency organizational structure and contact information.

 
Agency: Department of Health and Human Services(HHS)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
EO 14192 Designation: Deregulatory 
CFR Citation: 21 CFR 5   
Legal Authority: 5 U.S.C. 552    21 U.S.C. 301-397   
Legal Deadline:  None
Timetable:
Action Date FR Cite
Final Rule  07/00/2026 
Final Rule Effective  07/00/2026 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Small Entities Affected: No  Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Brian L. Pendleton
Senior Policy Advisor
Department of Health and Human Services
Food and Drug Administration
Suite 3037 (HFD-7), Office of Policy, 10903 New Hampshire Avenue, WO Building 32, Room 4250,
Silver Spring, MD 20993-0002
Phone:202 870-4765
Email: brian.pendleton@fda.hhs.gov